The Experts below are selected from a list of 360 Experts worldwide ranked by ideXlab platform
James E Tisdale - One of the best experts on this subject based on the ideXlab platform.
-
prevalence of qt interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of qt interval prolonging drugs
Drug Safety, 2012Co-Authors: James E Tisdale, Heather A Wroblewski, Brian R Overholser, Joanna R Kingery, Tate N Trujillo, Richard J KovacsAbstract:Background Cardiac arrest due to torsades de pointes (TdP) is a rare but Catastrophic Event in hospitals. Patients admitted to cardiac units are at higher risk of drug-induced QT interval prolongation and TdP, due to a preponderance of risk factors. Few data exist regarding the prevalence of QT interval prolongation in patients admitted to cardiac units or the frequency of administering QT interval-prolonging drugs to patients presenting with QT interval prolongation.
Richard J Kovacs - One of the best experts on this subject based on the ideXlab platform.
-
prevalence of qt interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of qt interval prolonging drugs
Drug Safety, 2012Co-Authors: James E Tisdale, Heather A Wroblewski, Brian R Overholser, Joanna R Kingery, Tate N Trujillo, Richard J KovacsAbstract:Background Cardiac arrest due to torsades de pointes (TdP) is a rare but Catastrophic Event in hospitals. Patients admitted to cardiac units are at higher risk of drug-induced QT interval prolongation and TdP, due to a preponderance of risk factors. Few data exist regarding the prevalence of QT interval prolongation in patients admitted to cardiac units or the frequency of administering QT interval-prolonging drugs to patients presenting with QT interval prolongation.
Brian R Overholser - One of the best experts on this subject based on the ideXlab platform.
-
prevalence of qt interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of qt interval prolonging drugs
Drug Safety, 2012Co-Authors: James E Tisdale, Heather A Wroblewski, Brian R Overholser, Joanna R Kingery, Tate N Trujillo, Richard J KovacsAbstract:Background Cardiac arrest due to torsades de pointes (TdP) is a rare but Catastrophic Event in hospitals. Patients admitted to cardiac units are at higher risk of drug-induced QT interval prolongation and TdP, due to a preponderance of risk factors. Few data exist regarding the prevalence of QT interval prolongation in patients admitted to cardiac units or the frequency of administering QT interval-prolonging drugs to patients presenting with QT interval prolongation.
Joanna R Kingery - One of the best experts on this subject based on the ideXlab platform.
-
prevalence of qt interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of qt interval prolonging drugs
Drug Safety, 2012Co-Authors: James E Tisdale, Heather A Wroblewski, Brian R Overholser, Joanna R Kingery, Tate N Trujillo, Richard J KovacsAbstract:Background Cardiac arrest due to torsades de pointes (TdP) is a rare but Catastrophic Event in hospitals. Patients admitted to cardiac units are at higher risk of drug-induced QT interval prolongation and TdP, due to a preponderance of risk factors. Few data exist regarding the prevalence of QT interval prolongation in patients admitted to cardiac units or the frequency of administering QT interval-prolonging drugs to patients presenting with QT interval prolongation.
Tate N Trujillo - One of the best experts on this subject based on the ideXlab platform.
-
prevalence of qt interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of qt interval prolonging drugs
Drug Safety, 2012Co-Authors: James E Tisdale, Heather A Wroblewski, Brian R Overholser, Joanna R Kingery, Tate N Trujillo, Richard J KovacsAbstract:Background Cardiac arrest due to torsades de pointes (TdP) is a rare but Catastrophic Event in hospitals. Patients admitted to cardiac units are at higher risk of drug-induced QT interval prolongation and TdP, due to a preponderance of risk factors. Few data exist regarding the prevalence of QT interval prolongation in patients admitted to cardiac units or the frequency of administering QT interval-prolonging drugs to patients presenting with QT interval prolongation.